Related Experiment Video
Updated: Mar 3, 2026
Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
Published on: January 19, 2019
Rewiring brain circuits to block cataplexy in murine models of narcolepsy
Meng Liu1, Carlos Blanco-Centurion1, Priyattam J Shiromani1
1Ralph H. Johnson VA and Medical University of South Carolina, Charleston, SC 29425, United States.
Abstract:
Narcolepsy was first identified almost 130 years ago, but it was only 15 years ago that it was identified as a neurodegenerative disease linked to a loss of orexin neurons in the brain. It is unclear what causes the orexin neurons to die, but our strategy has been to place the gene for orexin into surrogate neurons in the validated mouse models of narcolepsy, and test whether it can block narcolepsy symptoms, such as cataplexy. In both the orexin knockout and the orexin-ataxin-3 mouse models of narcolepsy we have found that cataplexy can be blocked if the surrogate neurons are part of the circuit responsible for cataplexy. We have also determined that the orexin gene can be inserted into surrogate neurons in the amygdala to block emotion-induced cataplexy. Through the use of optogenetics we anticipate that it will be possible to preemptively block cataplexy.
Insights
Researchers successfully blocked narcolepsy symptoms, like cataplexy, in mouse models by inserting the orexin gene into surrogate neurons. This neurodegenerative disease research offers new therapeutic strategies for narcolepsy.
Area of Science:
- Neuroscience
- Genetics
- Sleep Medicine
Background:
- Narcolepsy is a neurodegenerative disease characterized by the loss of orexin neurons.
- The exact cause of orexin neuron loss remains unknown.
- Narcolepsy symptoms include cataplexy, often triggered by emotions.
Purpose of the Study:
- To investigate if inserting the orexin gene into surrogate neurons can alleviate narcolepsy symptoms.
- To determine if the location of surrogate neurons impacts symptom blockage.
- To explore optogenetics for preemptive cataplexy prevention.
Main Methods:
- Gene therapy: inserting the orexin gene into surrogate neurons in mouse models of narcolepsy (orexin knockout and orexin-ataxin-3).
- Behavioral analysis: assessing the blockage of cataplexy.
- Circuit mapping: identifying the role of surrogate neuron location in symptom control.
- Optogenetics: exploring its potential for future therapeutic interventions.
Main Results:
- Successful blockage of cataplexy in both mouse models when surrogate neurons were integrated into the relevant neural circuit.
- Demonstrated that orexin gene insertion into amygdala surrogate neurons can block emotion-induced cataplexy.
- Established the feasibility of using surrogate neurons for orexin gene delivery.
Conclusions:
- Surrogate neuron-mediated orexin gene delivery is a viable strategy to block narcolepsy symptoms like cataplexy.
- Targeting specific neural circuits, such as those involving the amygdala, can effectively manage emotion-induced cataplexy.
- Optogenetics holds promise for preemptive treatment of narcolepsy symptoms.
More Related Videos
08:44Electrocorticographic Recording of Cerebral Cortex Areas Manipulated Using an Adeno-Associated Virus Targeting Cofilin in Mice
Published on: February 21, 2021
05:49Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders
Published on: November 1, 2024
